Core Insights - Privia Health Group, Inc. has entered into a partnership with Integrated Medical Services, Inc. (IMS) to expand its operations into Arizona, marking the 15th state in its national network [1][5] - The partnership will establish Privia Medical Group—Arizona, which aims to provide a new alternative for independent providers to care for patients across various reimbursement models [2][4] - The implementation of IMS on the Privia Platform is expected to occur in the fourth quarter of 2025, with profitability anticipated starting in the same quarter and for the full year of 2026 [3] Company Overview - Privia Health is one of the largest physician enablement companies in the U.S., operating in 15 states and the District of Columbia, and managing over 1,200 physician practices [5] - The company focuses on building scaled provider networks with a primary-care centric approach, utilizing a physician-led governance structure and a comprehensive technology and service platform [5][6] - Privia's mission is to transform healthcare delivery to achieve better outcomes, lower costs, and enhance community health and provider well-being [6] Partnership Details - IMS, with approximately 70 physicians and advanced practice providers, manages over 28,000 attributed lives across various value-based care arrangements [1][2] - The partnership is designed to maintain IMS's physician-owned and operated structure while leveraging Privia's expertise and technology to enhance patient care and practice vitality [4] - Both parties express a commitment to preserving IMS's culture and community focus while expanding their capabilities through this collaboration [4]

ARLINGTON, Va., April 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2025 before market open on Thursday, May 8, 2025. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company’s Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, ...

Privia Health (PRVA) reported $460.9 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 4.6%. EPS of $0.03 for the same period compares to $0.02 a year ago.The reported revenue represents a surprise of +10.37% over the Zacks Consensus Estimate of $417.6 million. With the consensus EPS estimate being $0.06, the EPS surprise was -50.00%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to det ...

Financial Data and Key Metrics Changes - Privia Health reported a strong performance in 2024, exceeding guidance metrics across the board, with implemented providers increasing by 11.2% year-over-year and fee-for-service collections growing by 13.6% [9][10] - Adjusted EBITDA rose by 25.2% to $90.5 million, with a care margin increase of 12.4% [20][21] - Free cash flow reached a record $109.3 million, converting 121% of adjusted EBITDA, with a cash balance of $491 million and no debt at year-end [10][22] Business Line Data and Key Metrics Changes - The growth in implemented providers was driven by solid ambulatory utilization trends and value-based performance, leading to practice collections of $792.5 million in Q4, a 4.7% increase year-over-year [20] - The company serves over 1.26 million attributed lives across various value-based care programs, with commercial attributed lives increasing by 15.2% [14][15] Market Data and Key Metrics Changes - The company operates in 14 states and the District of Columbia, with a footprint of 4,789 implemented providers caring for over 5.2 million patients [12][13] - Medicare Advantage and Medicaid attribution both increased nearly 8% year-over-year, while commercial attributed lives saw a 15.2% increase [15] Company Strategy and Development Direction - Privia aims to build one of the largest primary care-centric delivery networks in the nation, focusing on provider growth, attribution growth, and operational improvements [12][23] - The company plans to maintain a disciplined growth strategy, leveraging its strong balance sheet to pursue opportunities in existing and new markets [11][37] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating the challenging Medicare Advantage environment, emphasizing the importance of diversified value-based care contracts [15][16] - The company expects continued growth in EBITDA and free cash flow, with guidance for 2025 indicating strong performance despite headwinds [18][25] Other Important Information - The company has consistently expanded EBITDA margins and converted 105% of EBITDA to free cash flow on average since 2018 [17] - Management highlighted the importance of maintaining a robust pipeline for business development while assuming no new market entry costs in the 2025 guidance [26][112] Q&A Session Summary Question: Inquiry about OpEx and leverage between sales and marketing and G&A - Management indicated that the guidance reflects a scaling of the cost structure with no new market entry costs assumed, leading to operating leverage driving EBITDA growth [30][32] Question: Cash balance and M&A pipeline - Management confirmed a robust M&A pipeline, emphasizing a disciplined approach to capital deployment while remaining open to opportunities in the market [35][37] Question: Competitors evolving business models - Management stated that their approach to risk in value-based care remains consistent and that they do not see competitors' strategies as a threat [43][49] Question: Factors influencing flatness in Shared Savings - Management noted that the guidance assumes minimal growth in shared savings due to various factors, including utilization trends and regulatory changes [53][56] Question: Higher-than-expected EBITDA to cash flow conversion - Management explained that the conversion rate is expected to be around 80% due to the expiration of net operating loss carryforwards, impacting cash taxes [61][63] Question: Care Margin guidance and scenarios for upside - Management acknowledged that the flat assumption in value-based care shared savings is a key factor influencing care margin guidance [74][76] Question: Provider interest in Care Partners program - Management reported positive trends in provider interest and the integration of technology to enhance performance in value-based care [79][81] Question: Physician fee schedule and potential impacts - Management indicated that the current guidance incorporates best estimates regarding the physician fee schedule, with no material impact expected [84][86] Question: Impact of uninsured levels and Medicaid changes - Management noted limited exposure to Medicaid and the uninsured, with a diversified demographic mix across states [88][90] Question: New market entry versus existing market growth - Management expressed a commitment to pursuing growth in both existing and new markets, leveraging a proven business model [93][102] Question: Growth expectations for providers and attributed lives - Management explained that the expected growth in attributed lives is influenced by the mix of primary care and specialty providers [107][109] Question: Capitated book contribution margin - Management confirmed a positive contribution margin from the capitated book, with a cautious outlook for future capitation opportunities [140][142]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-K _______________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40365 _________________________ Privia Health Group, Inc. (Exact ...

4th Quarter 2024 Results February 27, 2025 Parth Mehrotra, CEO David Mountcastle, CFO Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company's opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2025 financial guidance and other projections and forecasts. These forward-looking statements involve a number of risks, uncertainties (some of whic ...

分组1 - Privia Health reported quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share, representing an earnings surprise of -50% [1] - The company posted revenues of $460.9 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 10.37%, compared to year-ago revenues of $440.83 million [2] - Privia Health shares have increased by approximately 23.1% since the beginning of the year, outperforming the S&P 500's gain of 1.3% [3] 分组2 - The current consensus EPS estimate for the coming quarter is $0.07 on revenues of $455.78 million, and $0.27 on revenues of $1.88 billion for the current fiscal year [7] - The Zacks Industry Rank indicates that the Medical Info Systems industry is currently in the top 34% of over 250 Zacks industries, suggesting a favorable outlook [8]

Full-Year Performance Exhibit 99.1 | | | | For the Years Ended December 31, | | | | --- | --- | --- | --- | --- | --- | | ($ in millions, except per share amounts) | | 2024 | | 2023 | * Change (%) | | Total revenue | $ | 1,736.4 | $ | 1,657.7 | 4.7 % | | Gross profit | $ | 397.7 | $ | 353.8 | 12.4 % | | Operating income | $ | 17.0 | $ | 20.6 | (17.8)% | | a Net income | $ | 14.4 | $ | 23.1 | (37.7)% | | b Non-GAAP adjusted net income | $ | 97.6 | $ | 81.5 | 19.8 % | | Net income per share | $ | 0.11 | $ | 0 ...

Core Insights - Privia Health Group, Inc. reported strong financial and operational results for the fourth quarter and full year ended December 31, 2024, exceeding the high end of its guidance ranges for 2024 [1] Full-Year Performance - Total revenue increased to $1,736.4 million in 2024, up 4.7% from $1,657.7 million in 2023 [2] - Gross profit rose to $397.7 million, reflecting a 12.4% increase from $353.8 million in 2023 [2] - Operating income decreased to $17.0 million, down 17.8% from $20.6 million in 2023 [2] - Net income fell to $14.4 million, a decline of 37.7% from $23.1 million in 2023 [2] - Non-GAAP adjusted net income increased to $97.6 million, up 19.8% from $81.5 million in 2023 [2] - Net income per share decreased to $0.11, down 42.1% from $0.19 in 2023 [2] - Non-GAAP adjusted net income per share increased to $0.78, up 21.9% from $0.64 in 2023 [2] Key Operating Metrics - Implemented Providers increased by 11.2% to 4,789 from 4,305 at year-end 2023 [5][7] - Attributed Lives grew by 12.1% to 1,256,000 from 1,120,000 in 2023 [7] - Practice Collections reached $2,968.0 million, a 4.5% increase from $2,839.0 million in 2023 [7] - Care Margin improved to $403.9 million, up 12.4% from $359.2 million in 2023 [7] - Adjusted EBITDA grew by 25.2% to $90.5 million from $72.2 million in 2023 [6][7] Fourth Quarter Performance - Total revenue for Q4 2024 was $460.9 million, a 4.6% increase from $440.8 million in Q4 2023 [9] - Gross profit for Q4 2024 was $106.1 million, up 18.0% from $90.0 million in Q4 2023 [9] - Operating income surged to $5.2 million, a 269.6% increase from $1.4 million in Q4 2023 [9] - Net income for Q4 2024 was $4.4 million, a 55.0% increase from $2.8 million in Q4 2023 [9] - Non-GAAP adjusted net income for Q4 2024 was $26.5 million, up 30.5% from $20.3 million in Q4 2023 [9] Capital Resources and Cash Flow - The cash balance at year-end 2024 was $491.1 million, a 26.1% increase from $389.5 million at year-end 2023 [12] - Net cash provided by operating activities for 2024 was $109.3 million, a 35.3% increase from $80.8 million in 2023 [12] - Free cash flow for 2024 was $109.3 million, up 35.4% from $80.7 million in 2023 [12] 2025 Financial and Business Outlook - The company expects to increase Implemented Providers to between 5,200 and 5,300, representing a year-over-year growth of 8.6% to 10.7% [13] - Attributed Lives are projected to grow to between 1,300,000 and 1,400,000, a 3.5% to 11.5% increase [13] - Practice Collections are expected to reach between $3,150 million and $3,250 million, reflecting a 6.1% to 9.5% increase [13] - GAAP Revenue guidance for 2025 is set between $1,800 million and $1,900 million, indicating a 3.7% to 9.4% increase [13]

Core Insights - Wall Street analysts anticipate Privia Health (PRVA) will report quarterly earnings of $0.06 per share, reflecting a year-over-year increase of 200% [1] - Expected revenues for the quarter are $417.6 million, which represents a decline of 5.3% compared to the same quarter last year [1] - The consensus EPS estimate has remained stable over the past 30 days, indicating a reevaluation of initial estimates by analysts [1] Earnings Estimates and Market Reactions - Changes in earnings estimates are critical for predicting investor reactions to stock performance [2] - Empirical studies show a strong correlation between earnings estimate revisions and short-term stock price performance [2] Key Metrics Projections - Analysts project 'Practice Collections' to reach $719.81 million, down from $756.60 million reported in the same quarter last year [4] - The estimated 'Care Margin' is $101.70 million, an increase from $91.45 million in the previous year [4] - The consensus for 'Platform Contribution' is expected to be $48.89 million, up from $42.28 million reported in the same quarter last year [5] Stock Performance - Privia Health shares have increased by 7.2% over the past month, contrasting with a -1.8% change in the Zacks S&P 500 composite [5] - With a Zacks Rank of 3 (Hold), PRVA is expected to perform in line with the overall market in the near future [5]